FAA finally publishes what medications pilots can safely take
H.R. 2592 — Aviation Medication Transparency Act of 2025 · Filed by Sean Casten (D-IL) · 24 cosponsors · Introduced Apr 2, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires the FAA to publish and maintain a public website listing medications that pilots and airmen can safely take while holding a medical certificate, along with information about stabilization periods and prohibited drugs. The list must be updated annually, drafted in consultation with pilot unions, air traffic controllers, and medical experts, and provided to airmen when they first apply for certification.
Why we flagged it
The bill's core function is to increase public transparency around FAA medication policy for airmen, making existing internal guidance accessible to pilots and their doctors. It is a straightforward disclosure and standardization mechanism with no hidden deregulation or carve-outs.
What the text implies
- Standardizing and publishing the medication list may reduce inconsistency in medical certification decisions, potentially allowing more pilots with treated medical conditions to maintain or obtain certificates if FAA guidance supports it.
- Providing doctors with a clear, accessible list and a mechanism to contact the FAA may increase medical provider engagement with aviation safety standards, improving the quality of medical evaluations for airmen.
The full analysis lists 3 implications of this text.
Who it affects
Ordinary pilots and airmen gain transparency about which medications are safe for their profession, reducing confusion and barriers to treatment for medical conditions. The public also benefits from clearer safety standards.